A Prospective Cohort Study to Determine the Sensitivity of Positron Emission Tomography (PET) in Detecting Metastatic Cancer in Neck Lymph Nodes in Patients With Squamous Cell Head & Neck Cancer Managed With Primary Radiation Therapy
PET-Fluorodeoxyglucose scanning is an imaging test based on the increased uptake of
radiolabelled glucose by tumour cells. PET might detect neck tumours better than other
imaging tests. This is a cohort study in which patients with N2 N3 squamous cell carcinoma
of the head and neck undergo a PET and a CT scan at baseline and then post-radiation therapy
and chemotherapy. Then, they undergo neck dissection surgery. The PET and CT results are
compared with the presence or absence of tumours in the neck nodes. If PET is sufficiently
accurate in predicting the presence or absence of tumours in the neck nodes, then a neck
dissection could be avoided.
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Ability of PET compared to CT in identifying the presence of tumour in neck nodes
2 years
No
John Waldron, MD
Study Chair
Princess Margaret Hospital, Canada
Canada: Health Canada
CTA-Control-088421
NCT00147472
May 2004
May 2011
Name | Location |
---|